RxDoctor Payments Data

Malachi Sheahan, MD

Vascular Surgery · Marrero, LANPI 1093726515

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.5%), grants and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 42.0% of the total. Reporting peaked in 2024 at $12,590 and has fallen 80.0% since, to $2,521 in 2025.

$26,543in general payments, 2019–2025

Across 185 payments — averaging $143.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$11K
  • W. L. Gore & Associates, Inc.$9K
  • Cook Medical LLC$2K
  • Penumbra, Inc.$2K
  • Vascular Technology, Inc.$700
  • Silk Road Medical, Inc.$285
  • plus $2K from 16 others

What the payments were for

  • Speaking & faculty fees$7003%
  • Grants$10,20338%
  • Travel & lodging$1060%
  • Food & beverage$15,53459%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,543 in reported general payments places this provider in the 85th percentile of 65 vascular surgery providers in Louisiana.

See all vascular surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$39,153
Medicare patients
101
Services billed
258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Marrero

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →